title: What is the role of erythropoietin in patients with solid tumours?
authors.forename: A
authors.initials: A
authors.lastname: Maraveyas
authors.forename: R
authors.initials: R
authors.lastname: Pettengell
mesh_terms: D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin